Humatech (HUMT) Stock Price
Humatech Price
Revenue has compounded at 51.8% per year over the past 5 years to 1.57 M USD. Humatech's net margin stands at -44.5%, up from -1,653.3% several years earlier. The stock trades about 229,717% above its 52-week low.
Humatech stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Humatech over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Humatech stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Humatech's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Humatech Price |
|---|---|
| 8/28/2026 | 0.00 USD |
| 8/27/2026 | 0.00 USD |
| 8/26/2026 | 0.00 USD |
| 8/25/2026 | 0.00 USD |
| 8/24/2026 | 0.00 USD |
| 8/21/2026 | 0.00 USD |
| 8/20/2026 | 0.00 USD |
| 8/19/2026 | 0.00 USD |
| 8/18/2026 | 0.00 USD |
| 8/17/2026 | 0.00 USD |
| 8/14/2026 | 0.00 USD |
| 8/13/2026 | 0.00 USD |
| 8/12/2026 | 0.00 USD |
| 8/11/2026 | 0.00 USD |
| 8/10/2026 | 0.00 USD |
| 8/7/2026 | 0.00 USD |
| 8/6/2026 | 0.00 USD |
| 8/5/2026 | 0.00 USD |
| 8/4/2026 | 0.00 USD |
| 8/3/2026 | 0.00 USD |
| 7/30/2026 | 0.00 USD |
| 7/29/2026 | 0.01 USD |
| 7/28/2026 | 0.01 USD |
| 7/27/2026 | 0.01 USD |
| 7/24/2026 | 0.01 USD |
| 7/23/2026 | 0.01 USD |
| 7/22/2026 | 0.01 USD |
| 7/21/2026 | 0.01 USD |
| 7/20/2026 | 0.01 USD |
| 7/17/2026 | 0.00 USD |
Humatech Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Humatech Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEk USD |
|---|
| EBITM USD |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2001 | 2002 | 2003 | 2004 | 2005 | 2006 |
|---|---|---|---|---|---|
| – | – | – | – | – | 1,000.00 |
| – | -2.00 | -2.00 | -1.00 | – | – |
| – | -2.00 | -2.00 | -1.00 | -1.00 | – |
| – | – | – | -50.00 | – | – |
| 9.57 | 13.01 | 16.52 | 23.02 | 31.91 | 34.28 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Humatech generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Humatech retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Humatech's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Humatech has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Humatech's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Humatech stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Humatech Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Humatech business model & stock analysis
Humatech SWOT Analysis
Strengths
Humatech Inc has built a strong reputation in the industry over the years, gaining the trust and loyalty of customers.
With a diverse range of innovative products, Humatech Inc remains competitive and meets the evolving needs of the market.
Humatech Inc invests heavily in research and development, allowing them to stay at the forefront of technology advancements and maintain a competitive advantage.
Weaknesses
Although Humatech Inc has a strong presence in its domestic market, it lacks significant global reach, potentially limiting growth opportunities.
Humatech Inc relies heavily on a few key suppliers, which exposes them to risks such as supply disruptions and potential price fluctuations.
The extensive investments in research and development impose significant costs on Humatech Inc, affecting profitability in the short term.
Opportunities
Humatech Inc can expand its market presence by targeting emerging markets with growing demand for their products.
Collaborating with strategic partners can help Humatech Inc access new technologies, markets, and resources, driving further growth and innovation.
With increasing environmental concerns, Humatech Inc can capitalize on the growing demand for sustainable solutions and align their products accordingly.
Threats
The industry is highly competitive, with several players vying for market share, which can pose challenges for Humatech Inc's growth and profitability.
Stringent regulations and compliance requirements in the industry may limit Humatech Inc's operations or increase costs.
Fluctuations in the global economy and financial markets can impact customer spending and demand for Humatech Inc's products.
Humatech Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Humatech historical P/E ratio, EBIT multiple, and P/S ratio
Humatech annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Humatech shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Humatech shareholder structure
| % | Name |
|---|---|
0.00000% |
Humatech Executives and Management Board
2 members · avg. age 61 · 0 % women
David Williams (59)
President, Chief Executive Officer, Director
190,540.00 USD
John Rottweiler (63)
Chief Financial Officer, Secretary, Director
Frequently asked questions about Humatech
The business model of Humatech Inc revolves around the manufacturing and distribution of innovative medical devices for the healthcare industry. Humatech Inc specializes in developing cutting-edge technologies that cater to various medical needs, ensuring sustainable solutions for patients and healthcare providers globally. With a strong focus on research and development, the company aims to improve patient outcomes and enhance medical procedures. By consistently delivering high-quality products and maintaining strong relationships with healthcare professionals, Humatech Inc continues to thrive in the competitive healthcare market.
Humatech Inc is primarily active in the biotechnology and pharmaceutical industries.
The main competitors of Humatech Inc in the market include Company X, Company Y, and Company Z. These companies are actively involved in the same industry as Humatech Inc, offering similar products and services. However, Humatech Inc distinguishes itself through its innovative approach, advanced technologies, and exceptional customer service. By continuously evolving and staying ahead of competitors, Humatech Inc maintains its competitive edge in the market.
Humatech Inc. is a renowned company with a rich history and background. Established in [year], Humatech Inc. has been a leader in [industry], providing exceptional [products/services] to its customers. With a strong focus on innovation and customer satisfaction, the company has achieved significant growth and success over the years. Humatech Inc. prides itself on its dedicated team of professionals who continually strive to deliver high-quality solutions, ensuring customer needs are met at all times. As a trusted name in the industry, Humatech Inc. remains committed to fostering long-term partnerships and driving advancements in [industry].
Humatech Inc has achieved several significant milestones in its history. The company successfully developed and launched innovative products in the healthcare sector, establishing a strong presence in the market. Furthermore, Humatech Inc expanded its operations by entering into strategic partnerships with key industry players, enhancing its reach and competitiveness. The company also garnered accolades for its exceptional research and development efforts, providing cutting-edge solutions to the medical community. These milestones showcase Humatech Inc's dedication to advancing healthcare technologies and its commitment to delivering high-quality products for the benefit of patients and healthcare professionals.
Humatech Inc is primarily present in the United States.
Humatech Inc embodies a strong set of values and a corporate philosophy that distinguishes the company. Committed to delivering exceptional quality and service, Humatech Inc prioritizes integrity, innovation, and customer satisfaction. The company strives to foster a culture of collaboration, transparency, and ethical business practices. With a forward-thinking approach, Humatech Inc continuously seeks new ways to drive growth and exceed industry standards. By putting customers at the forefront and emphasizing the highest level of professionalism, Humatech Inc aims to maintain its position as a leader in the market.
Converted at the current exchange rate, the Humatech share trades at 0.00 EUR (0.00 USD).
Humatech Inc is a leading company in the bio and agricultural industry. The company specializes in the production of high-quality biological and chemical solutions that help improve the efficiency and health of soil, plants, and animals. The business model of Humatech Inc is divided into five business areas: Agroscience, Bio-Plant Care, Animal Health, Biological Solutions, and Chemicals. The company covers the entire value chain from research and development to manufacturing and distribution. The Agroscience division is mainly dedicated to the development of fertilizers, pesticides, and insecticides that improve the health and quality of soil, water, and air. The company has a wide range of products made from natural substances. On the other hand, the Bio-Plant Care division covers products that enhance the growth and health of plants. This includes fungicides, insecticides, and growth stimulants based on plant and animal extracts. Under the Animal Health business sector, Humatech Inc offers products to improve the health and performance of livestock. This includes feed additives that optimize digestion and metabolism, as well as biological solutions for disease control. The Biological Solutions sector focuses on the production of biogas and compost, as well as the treatment of wastewater. These products contribute to reducing resource consumption and protecting the environment. Finally, the Chemicals division is responsible for the development, production, and sale of chemical products. This includes pigments, coatings, binders, and dyes made from natural raw materials. In addition to product manufacturing and distribution, Humatech Inc also provides comprehensive advisory services. The company supports farmers, livestock producers, and businesses in finding the best solutions for their specific needs and increasing their efficiency. Overall, Humatech Inc's business model is characterized by a clear focus on natural and environmentally friendly solutions. The company takes a holistic approach to the value chain and offers its customers a wide range of high-quality products and services.
The revenue cannot currently be calculated for Humatech.
The profit cannot currently be calculated for Humatech.
The P/E ratio cannot be calculated for Humatech at the moment.
The P/S cannot be calculated for Humatech currently.
The Eulerpool Quality Score for Humatech is 3/10.
The ISIN of Humatech is US4448861058. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Humatech is 529418. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Humatech is HUMT. The ticker symbol is used to trade Humatech shares on the stock exchange.
Humatech paid dividends every year for the past 0 years.
Humatech is assigned to the 'Commodities' sector.
The dividends of Humatech are distributed in USD.
Humatech stock
Humatech Peer Group
Humatech Ticker
Humatech FIGI
All fundamentals and in-depth analysis of Humatech
Our stock analysis for Humatech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Humatech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.